Upper  ||| S:0 E:6 ||| JJ
ankle  ||| S:6 E:12 ||| JJ
joint  ||| S:12 E:18 ||| JJ
prostheses  ||| S:18 E:29 ||| NN
in  ||| S:29 E:32 ||| IN
haemophilia  ||| S:32 E:44 ||| JJ
patients  ||| S:44 E:53 ||| NNS
Secondary  ||| S:53 E:63 ||| JJ
arthrosis  ||| S:63 E:73 ||| NN
of  ||| S:73 E:76 ||| IN
the  ||| S:76 E:80 ||| DT
upper  ||| S:80 E:86 ||| JJ
ankle  ||| S:86 E:92 ||| JJ
joint  ||| S:92 E:98 ||| JJ
( ||| S:98 E:99 ||| -LRB-
talocalcanean  ||| S:99 E:113 ||| JJ
joint ||| S:113 E:118 ||| JJ
)  ||| S:118 E:120 ||| -RRB-
is  ||| S:120 E:123 ||| VBZ
one  ||| S:123 E:127 ||| CD
of  ||| S:127 E:130 ||| IN
the  ||| S:130 E:134 ||| DT
most  ||| S:134 E:139 ||| RBS
frequent  ||| S:139 E:148 ||| JJ
forms  ||| S:148 E:154 ||| NNS
of  ||| S:154 E:157 ||| IN
haemophilic  ||| S:157 E:169 ||| JJ
arthropathy ||| S:169 E:180 ||| NN
.  ||| S:180 E:182 ||| .
It  ||| S:182 E:185 ||| PRP
is  ||| S:185 E:188 ||| VBZ
a  ||| S:188 E:190 ||| DT
secondary  ||| S:190 E:200 ||| JJ
form  ||| S:200 E:205 ||| NN
of  ||| S:205 E:208 ||| IN
arthrosis  ||| S:208 E:218 ||| VBG
not  ||| S:218 E:222 ||| RB
only  ||| S:222 E:227 ||| RB
because  ||| S:227 E:235 ||| IN
of  ||| S:235 E:238 ||| IN
chronic  ||| S:238 E:246 ||| JJ
synovitis  ||| S:246 E:256 ||| NN
and  ||| S:256 E:260 ||| CC
cartilage  ||| S:260 E:270 ||| JJ
injury  ||| S:270 E:277 ||| NN
resulting  ||| S:277 E:287 ||| VBG
from  ||| S:287 E:292 ||| IN
chronic  ||| S:292 E:300 ||| FW
recurrent  ||| S:300 E:310 ||| FW
intraarticular  ||| S:310 E:325 ||| FW
bleeds ||| S:325 E:331 ||| FW
,  ||| S:331 E:333 ||| ,
but  ||| S:333 E:337 ||| CC
also  ||| S:337 E:342 ||| RB
due  ||| S:342 E:346 ||| JJ
to  ||| S:346 E:349 ||| TO
the  ||| S:349 E:353 ||| DT
misalignment  ||| S:353 E:366 ||| NN
of  ||| S:366 E:369 ||| IN
the  ||| S:369 E:373 ||| DT
joint  ||| S:373 E:379 ||| JJ
and  ||| S:379 E:383 ||| CC
abnormal  ||| S:383 E:392 ||| JJ
joint  ||| S:392 E:398 ||| JJ
stress ||| S:398 E:404 ||| NN
.  ||| S:404 E:406 ||| .
The  ||| S:406 E:410 ||| DT
consequences  ||| S:410 E:423 ||| NNS
are  ||| S:423 E:427 ||| VBP
manifest  ||| S:427 E:436 ||| VBN
even  ||| S:436 E:441 ||| RB
in  ||| S:441 E:444 ||| IN
young  ||| S:444 E:450 ||| JJ
patients  ||| S:450 E:459 ||| NNS
and  ||| S:459 E:463 ||| CC
finally  ||| S:463 E:471 ||| RB
lead  ||| S:471 E:476 ||| VB
to  ||| S:476 E:479 ||| TO
subtalar  ||| S:479 E:488 ||| VB
joint  ||| S:488 E:494 ||| JJ
ankylosis  ||| S:494 E:504 ||| NN
with  ||| S:504 E:509 ||| IN
the  ||| S:509 E:513 ||| DT
biomechanical  ||| S:513 E:527 ||| JJ
disorder  ||| S:527 E:536 ||| NN
of  ||| S:536 E:539 ||| IN
foot  ||| S:539 E:544 ||| NN
drop  ||| S:544 E:549 ||| NN
( ||| S:549 E:550 ||| -LRB-
talipes  ||| S:550 E:558 ||| FW
equinus ||| S:558 E:565 ||| FW
) ||| S:565 E:566 ||| -RRB-
.  ||| S:566 E:568 ||| .
In  ||| S:568 E:571 ||| IN
such  ||| S:571 E:576 ||| JJ
clinical  ||| S:576 E:585 ||| JJ
situations ||| S:585 E:595 ||| NNS
,  ||| S:595 E:597 ||| ,
implantation  ||| S:597 E:610 ||| NN
of  ||| S:610 E:613 ||| IN
a  ||| S:613 E:615 ||| DT
subtalar  ||| S:615 E:624 ||| JJ
joint  ||| S:624 E:630 ||| JJ
endoprosthesis  ||| S:630 E:645 ||| NN
is  ||| S:645 E:648 ||| VBZ
a  ||| S:648 E:650 ||| DT
viable  ||| S:650 E:657 ||| JJ
alternative  ||| S:657 E:669 ||| NN
to  ||| S:669 E:672 ||| TO
arthrodesis ||| S:672 E:683 ||| VB
.  ||| S:683 E:685 ||| .
A  ||| S:685 E:687 ||| DT
man  ||| S:687 E:691 ||| NN
( ||| S:691 E:692 ||| -LRB-
age ||| S:692 E:695 ||| NN
:  ||| S:695 E:697 ||| :
52  ||| S:697 E:700 ||| CD
years ||| S:700 E:705 ||| NNS
) ||| S:705 E:706 ||| -RRB-
,  ||| S:706 E:708 ||| ,
suffering  ||| S:708 E:718 ||| VBG
from  ||| S:718 E:723 ||| IN
severe  ||| S:723 E:730 ||| JJ
haemophilia  ||| S:730 E:742 ||| NNS
A  ||| S:742 E:744 ||| DT
( ||| S:744 E:745 ||| -LRB-
residual  ||| S:745 E:754 ||| JJ
FVIII  ||| S:754 E:760 ||| NNP
activity  ||| S:760 E:769 ||| NN
< ||| S:769 E:771 ||| SYM
1  ||| S:771 E:773 ||| CD
% ||| S:773 E:774 ||| NN
) ||| S:774 E:775 ||| -RRB-
,  ||| S:775 E:777 ||| ,
no  ||| S:777 E:780 ||| DT
inhibitor  ||| S:780 E:790 ||| JJ
formation ||| S:790 E:799 ||| NN
.  ||| S:799 E:801 ||| .
The  ||| S:801 E:805 ||| DT
patient  ||| S:805 E:813 ||| NN
has  ||| S:813 E:817 ||| VBZ
a  ||| S:817 E:819 ||| DT
history  ||| S:819 E:827 ||| NN
of  ||| S:827 E:830 ||| IN
several  ||| S:830 E:838 ||| JJ
years  ||| S:838 E:844 ||| NNS
of  ||| S:844 E:847 ||| IN
painful  ||| S:847 E:855 ||| JJ
ankylosis  ||| S:855 E:865 ||| NN
of  ||| S:865 E:868 ||| IN
the  ||| S:868 E:872 ||| DT
right  ||| S:872 E:878 ||| JJ
ankle  ||| S:878 E:884 ||| JJ
joint  ||| S:884 E:890 ||| JJ
and  ||| S:890 E:894 ||| CC
minor  ||| S:894 E:900 ||| JJ
talipes  ||| S:900 E:908 ||| JJ
equinus ||| S:908 E:915 ||| NN
,  ||| S:915 E:917 ||| ,
and  ||| S:917 E:921 ||| CC
suffers  ||| S:921 E:929 ||| VBZ
from  ||| S:929 E:934 ||| IN
symptomatic  ||| S:934 E:946 ||| JJ
talonavicular  ||| S:946 E:960 ||| JJ
arthrosis ||| S:960 E:969 ||| NN
.  ||| S:969 E:971 ||| .
Open  ||| S:971 E:976 ||| JJ
joint  ||| S:976 E:982 ||| JJ
cleansing  ||| S:982 E:992 ||| NN
considerably  ||| S:992 E:1005 ||| RB
improved  ||| S:1005 E:1014 ||| JJ
mobility  ||| S:1014 E:1023 ||| NN
in  ||| S:1023 E:1026 ||| IN
the  ||| S:1026 E:1030 ||| DT
upper  ||| S:1030 E:1036 ||| JJ
ankle  ||| S:1036 E:1042 ||| JJ
joint  ||| S:1042 E:1048 ||| JJ
and  ||| S:1048 E:1052 ||| CC
alleviated  ||| S:1052 E:1063 ||| VBG
the  ||| S:1063 E:1067 ||| DT
pain  ||| S:1067 E:1072 ||| NN
in  ||| S:1072 E:1075 ||| IN
the  ||| S:1075 E:1079 ||| DT
talonavicular  ||| S:1079 E:1093 ||| JJ
joint ||| S:1093 E:1098 ||| JJ
.  ||| S:1098 E:1100 ||| .
However ||| S:1100 E:1107 ||| RB
,  ||| S:1107 E:1109 ||| ,
the  ||| S:1109 E:1113 ||| DT
recovered  ||| S:1113 E:1123 ||| JJ
mobility  ||| S:1123 E:1132 ||| NN
of  ||| S:1132 E:1135 ||| IN
the  ||| S:1135 E:1139 ||| DT
arthrotic  ||| S:1139 E:1149 ||| JJ
upper  ||| S:1149 E:1155 ||| JJ
ankle  ||| S:1155 E:1161 ||| JJ
joint  ||| S:1161 E:1167 ||| NN
also  ||| S:1167 E:1172 ||| RB
activated  ||| S:1172 E:1182 ||| VBN
the  ||| S:1182 E:1186 ||| DT
patient ||| S:1186 E:1193 ||| NN
's  ||| S:1193 E:1196 ||| POS
arthrosis ||| S:1196 E:1205 ||| NN
,  ||| S:1205 E:1207 ||| ,
associated  ||| S:1207 E:1218 ||| VBN
with  ||| S:1218 E:1223 ||| IN
severe  ||| S:1223 E:1230 ||| JJ
pain ||| S:1230 E:1234 ||| NN
.  ||| S:1234 E:1236 ||| .
As  ||| S:1236 E:1239 ||| IN
there  ||| S:1239 E:1245 ||| EX
was  ||| S:1245 E:1249 ||| VBD
no  ||| S:1249 E:1252 ||| DT
contraindication  ||| S:1252 E:1269 ||| NN
to  ||| S:1269 E:1272 ||| TO
upper  ||| S:1272 E:1278 ||| JJ
ankle  ||| S:1278 E:1284 ||| JJ
joint  ||| S:1284 E:1290 ||| JJ
replacement ||| S:1290 E:1301 ||| NN
,  ||| S:1301 E:1303 ||| ,
a  ||| S:1303 E:1305 ||| DT
cement-free  ||| S:1305 E:1317 ||| JJ
prosthesis  ||| S:1317 E:1328 ||| NN
was  ||| S:1328 E:1332 ||| VBD
implanted ||| S:1332 E:1341 ||| VBN
.  ||| S:1341 E:1343 ||| .
Three  ||| S:1343 E:1349 ||| CD
months  ||| S:1349 E:1356 ||| NNS
after  ||| S:1356 E:1362 ||| IN
surgery ||| S:1362 E:1369 ||| NN
,  ||| S:1369 E:1371 ||| ,
the  ||| S:1371 E:1375 ||| DT
patient  ||| S:1375 E:1383 ||| NN
was  ||| S:1383 E:1387 ||| VBD
mobile ||| S:1387 E:1393 ||| JJ
,  ||| S:1393 E:1395 ||| ,
with  ||| S:1395 E:1400 ||| IN
good  ||| S:1400 E:1405 ||| JJ
foot  ||| S:1405 E:1410 ||| NN
rolling  ||| S:1410 E:1418 ||| VBG
properties  ||| S:1418 E:1429 ||| NNS
without  ||| S:1429 E:1437 ||| IN
orthopedic  ||| S:1437 E:1448 ||| JJ
aids ||| S:1448 E:1452 ||| NNS
,  ||| S:1452 E:1454 ||| ,
and  ||| S:1454 E:1458 ||| CC
without  ||| S:1458 E:1466 ||| IN
pain  ||| S:1466 E:1471 ||| NN
in  ||| S:1471 E:1474 ||| IN
his  ||| S:1474 E:1478 ||| PRP$
upper  ||| S:1478 E:1484 ||| JJ
joint  ||| S:1484 E:1490 ||| JJ
ankle ||| S:1490 E:1495 ||| NN
.  ||| S:1495 E:1497 ||| .
In  ||| S:1497 E:1500 ||| IN
terms  ||| S:1500 E:1506 ||| NNS
of  ||| S:1506 E:1509 ||| IN
biomechanics  ||| S:1509 E:1522 ||| VBG
an  ||| S:1522 E:1525 ||| DT
upper  ||| S:1525 E:1531 ||| JJ
ankle  ||| S:1531 E:1537 ||| JJ
joint  ||| S:1537 E:1543 ||| JJ
endoprosthesis  ||| S:1543 E:1558 ||| NN
is  ||| S:1558 E:1561 ||| VBZ
a  ||| S:1561 E:1563 ||| DT
superior  ||| S:1563 E:1572 ||| JJ
alternative  ||| S:1572 E:1584 ||| NN
to  ||| S:1584 E:1587 ||| TO
arthrodesis  ||| S:1587 E:1599 ||| VB
in  ||| S:1599 E:1602 ||| IN
haemophilia  ||| S:1602 E:1614 ||| JJ
patients ||| S:1614 E:1622 ||| NNS
.  ||| S:1622 E:1624 ||| .
In  ||| S:1624 E:1627 ||| IN
order  ||| S:1627 E:1633 ||| NN
to  ||| S:1633 E:1636 ||| TO
minimize  ||| S:1636 E:1645 ||| VB
the  ||| S:1645 E:1649 ||| DT
complication  ||| S:1649 E:1662 ||| JJ
rate ||| S:1662 E:1666 ||| NN
,  ||| S:1666 E:1668 ||| ,
the  ||| S:1668 E:1672 ||| DT
treatment  ||| S:1672 E:1682 ||| NN
of  ||| S:1682 E:1685 ||| IN
haemophilia  ||| S:1685 E:1697 ||| JJ
patients  ||| S:1697 E:1706 ||| NNS
should  ||| S:1706 E:1713 ||| MD
be  ||| S:1713 E:1716 ||| VB
restricted  ||| S:1716 E:1727 ||| VBN
to  ||| S:1727 E:1730 ||| TO
specially  ||| S:1730 E:1740 ||| VB
equipped  ||| S:1740 E:1749 ||| VBN
interdisciplinary  ||| S:1749 E:1767 ||| JJ
treatment  ||| S:1767 E:1777 ||| NN
centers  ||| S:1777 E:1785 ||| NNS
with  ||| S:1785 E:1790 ||| IN
adequately  ||| S:1790 E:1801 ||| RB
trained  ||| S:1801 E:1809 ||| VBN
and  ||| S:1809 E:1813 ||| CC
experienced  ||| S:1813 E:1825 ||| JJ
surgeons  ||| S:1825 E:1834 ||| NN
as  ||| S:1834 E:1837 ||| IN
well  ||| S:1837 E:1842 ||| RB
as  ||| S:1842 E:1845 ||| IN
haemostaseologists ||| S:1845 E:1863 ||| NN
.  ||| S:1863 E:1865 ||| .
